AVITA Medical Inc. (RCEL)
NASDAQ: RCEL
· Real-Time Price · USD
5.75
-0.05 (-0.86%)
At close: Aug 15, 2025, 2:20 PM
AVITA Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.92M | -13.86M | -11.59M | -16.2M | -15.39M | -18.66M | -7.07M | -8.71M | -10.38M | -9.22M | -5.35M | -5.59M | -6.26M | -9.46M | -8.48M | -5.95M | -4.72M | -6M |
Depreciation & Amortization | 552K | 521K | 409K | 310K | 204K | 203K | 187K | 164K | 146K | 135K | 130K | 138K | 137K | 163K | 241K | 174K | 175K | 167K |
Stock-Based Compensation | 2.67M | 2.69M | 2.8M | 4.08M | 4.03M | 2.59M | 2.17M | 2.43M | 1.14M | 2.64M | 1.22M | 1.44M | 1.41M | 2.93M | 1.75M | 1.84M | 1.41M | 1.33M |
Other Working Capital | -2.62M | -397K | 1.4M | 2.25M | 1.99M | -4.33M | 1.94M | -898K | 1.16M | -2.58M | 736K | 562K | 1.24M | -2.66M | 1.67M | 309K | 890K | -2.68M |
Other Non-Cash Items | -1.75M | 94K | 1.05M | 2.24M | -1.57M | 1.25M | -6.16M | 53K | 327K | 707K | 290K | 257K | 207K | 451K | 161K | 321K | 388K | 854K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.79M | 241K | -746K | 2.36M | -51K | -6.25M | 3K | -2.91M | -333K | -3.33M | 281K | 980K | 996K | -3.45M | 1.42M | 3.04M | -1.21M | -4.92M |
Operating Cash Flow | -10.23M | -10.31M | -8.08M | -7.21M | -12.78M | -20.86M | -10.86M | -8.97M | -9.1M | -9.07M | -3.44M | -2.78M | -3.51M | -9.37M | -4.91M | -572K | -3.95M | -8.56M |
Capital Expenditures | -524K | -234K | -1.63M | -3.82M | -2.65M | -1.23M | -330K | -512K | -304K | -301K | -90K | -125K | -234K | -76K | 3K | -88K | -201K | -338K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.46M | n/a | -5.89M | -12.79M | -2.92M | -2.9M | -71.12M | n/a | -2.45M | -5.18M | -14.95M | -26.43M | -7.45M | -25.52M | n/a | -49.55M | n/a | n/a |
Sales Maturities Of Investments | 11M | 11M | 10M | 24M | 18M | 19.2M | 14.15M | 22.27M | 21.12M | 24.27M | 11.89M | 18.23M | 22.44M | 3M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -13K | -22K | -56K | -1K | -83K | -34K | -10K | -5K | -17K | -20K | -21K | -20K | -12K | -29K | -21K | -82K | -35K |
Investing Cash Flow | 7.02M | 10.77M | 2.47M | 7.39M | 12.43M | 15.07M | -57.3M | 21.76M | 18.36M | 18.79M | -3.16M | -8.33M | 14.76M | -22.6M | -26K | -49.64M | -201K | -338K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 544.04K | 363K | 1.02M | 1.01M | 849K | 631K | 39.43M | 600K | 171K | 171K | 899K | n/a | n/a | 1K | 4K | 3K | 31K | -5.08M |
Financial Cash Flow | 559K | 363K | 1.02M | 1.01M | 849K | 631K | 39.43M | 600K | 171K | 171K | 899K | n/a | n/a | 1K | 4K | 3K | 31K | 64.03M |
Net Cash Flow | -2.65M | 820K | -4.59M | 1.19M | 501K | -5.17M | -28.74M | 13.37M | 9.44M | 9.89M | -5.65M | -11.12M | 11.2M | -31.98M | -4.13M | -50.26M | -4.13M | 55.11M |
Free Cash Flow | -10.75M | -10.54M | -9.71M | -11.03M | -15.43M | -22.09M | -11.19M | -9.49M | -9.4M | -9.37M | -3.53M | -2.9M | -3.74M | -9.45M | -4.91M | -660K | -4.15M | -8.9M |